Asxl1 deficiency in embryonic fibroblasts leads to cellular senescence via impairment of the AKT-E2F pathway and Ezh2 inactivation
Abstract Although ASXL1 mutations are frequently found in human diseases, including myeloid leukemia, the cell proliferation–associated function of ASXL1 is largely unknown. Here, we explored the molecular mechanism underlying the growth defect found in Asxl1-deficient mouse embryonic fibroblasts (M...
Enregistré dans:
Auteurs principaux: | Hye Sook Youn, Tae-Yoon Kim, Ui-Hyun Park, Seung-Tae Moon, So-Jung An, Yong-Kyu Lee, Jin-Taek Hwang, Eun-Joo Kim, Soo-Jong Um |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/aeedf74d7e724fa6bb3f01a2f6594b3d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Loss of Asxl2 leads to myeloid malignancies in mice
par: Jianping Li, et autres
Publié: (2017) -
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
par: Yi Bao, et autres
Publié: (2020) -
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
par: Jean-Baptiste Micol, et autres
Publié: (2017) -
EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy
par: Julian C. Lui, et autres
Publié: (2016) -
BAP1/ASXL1 recruitment and activation for H2A deubiquitination
par: Danny D. Sahtoe, et autres
Publié: (2016)